Aptorum Group Ltd (APM)
5.45
+0.57
(+11.68%)
USD |
NASDAQ |
Apr 30, 16:00
5.39
-0.06
(-1.10%)
Pre-Market: 20:00
Aptorum Group 1 Year Total Returns (Daily): 115.4% for April 30, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 30, 2024 | 115.4% |
April 29, 2024 | 92.89% |
April 26, 2024 | 82.07% |
April 25, 2024 | 97.83% |
April 24, 2024 | 89.12% |
April 23, 2024 | 98.56% |
April 22, 2024 | 104.3% |
April 19, 2024 | 101.0% |
April 18, 2024 | 75.49% |
April 17, 2024 | 130.0% |
April 16, 2024 | 200.0% |
April 15, 2024 | 207.8% |
April 12, 2024 | 254.6% |
April 11, 2024 | 264.8% |
April 10, 2024 | 279.6% |
April 09, 2024 | 252.9% |
April 08, 2024 | 248.0% |
April 05, 2024 | 220.0% |
April 04, 2024 | 281.9% |
April 03, 2024 | 293.7% |
April 02, 2024 | 273.4% |
April 01, 2024 | 260.8% |
March 28, 2024 | 183.3% |
March 27, 2024 | 167.7% |
March 26, 2024 | 198.6% |
Date | Value |
---|---|
March 25, 2024 | 162.2% |
March 22, 2024 | 189.2% |
March 21, 2024 | 243.8% |
March 20, 2024 | 263.2% |
March 19, 2024 | 297.3% |
March 18, 2024 | 223.4% |
March 15, 2024 | 192.2% |
March 14, 2024 | 143.1% |
March 13, 2024 | 65.27% |
March 12, 2024 | 89.41% |
March 11, 2024 | 130.6% |
March 08, 2024 | 145.7% |
March 07, 2024 | 115.1% |
March 06, 2024 | 208.1% |
March 05, 2024 | -58.69% |
March 04, 2024 | -56.13% |
March 01, 2024 | -50.76% |
February 29, 2024 | -49.71% |
February 28, 2024 | -49.20% |
February 27, 2024 | -49.85% |
February 26, 2024 | -50.85% |
February 23, 2024 | -53.97% |
February 22, 2024 | -53.08% |
February 21, 2024 | -53.28% |
February 20, 2024 | -56.51% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.33%
Minimum
Sep 28 2020
297.3%
Maximum
Mar 19 2024
-46.14%
Average
-62.89%
Median
1 Year Total Returns (Daily) Benchmarks
TC BioPharm (Holdings) PLC | -93.56% |
Renalytix PLC | -70.81% |
Immuron Ltd | 4.72% |
Adaptimmune Therapeutics PLC | -16.48% |
Biodexa Pharmaceuticals Plc | -91.88% |